Particularly, in patients considered for salvage radiation treatment, PSMA PET/CT has a high detection rate of prostate cancer lesions outside the prostatic fossa [15], corresponding to the number of men failing after salvage irradiation of the prostate fossa. This evidence concerns the gene FOLH1 and Familial prostate cancer.